Parthenolide sensitizes hepatocellular carcinoma cells to TRAIL by inducing the expression of death receptors through inhibition of STAT3 activation. (Q54603551)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Parthenolide sensitizes hepatocellular carcinoma cells to TRAIL by inducing the expression of death receptors through inhibition of STAT3 activation.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21413021%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Parthenolide sensitizes hepatocellular carcinoma cells to TRAIL by inducing the expression of death receptors through inhibition of STAT3 activation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21413021%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

Daniela Carlisi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21413021%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Antonella D'Anneo

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21413021%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Giovanni Tesoriere

8

object named as

Giovanni Tesoriere

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21413021%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

7

object named as

Renza Vento

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21413021%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Marianna Lauricella

4

object named as

Marianna Lauricella

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21413021%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

5

object named as

Sonia Emanuele

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21413021%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Andrea Santulli

6

object named as

Andrea Santulli

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21413021%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

Liliana Angileri

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21413021%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

publication date

1 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21413021%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Journal of Cellular Physiology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21413021%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

226

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21413021%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21413021%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1632-1641

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21413021%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

NF-kappa B: ten years after

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

An essential role for NF-kappaB in preventing TNF-alpha-induced cell death

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

TRAIL receptor-2 signals apoptosis through FADD and caspase-8

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

Sesquiterpene lactone containing Mexican Indian medicinal plants and pure sesquiterpene lactones as potent inhibitors of transcription factor NF-kappaB.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

STATs in oncogenesis

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

The histone deacetylase inhibitor suberoylanilide hydroxamic acid sensitises human hepatocellular carcinoma cells to TRAIL-induced apoptosis by TRAIL-DISC activation.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

Differential responsiveness of human hepatoma cells versus normal hepatocytes to TRAIL in combination with either histone deacetylase inhibitors or conventional cytostatics

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

SAHA induces apoptosis in hepatoma cells and synergistically interacts with the proteasome inhibitor Bortezomib

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

Parthenolide promotes the ubiquitination of MDM2 and activates p53 cellular functions.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

STATs: signal transducers and activators of transcription

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

Inhibition of ataxia telangiectasia mutated kinase activity enhances TRAIL-mediated apoptosis in human melanoma cells

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

Susceptibility of cholangiocarcinoma cells to parthenolide-induced apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

Effects of the sesquiterpene lactone parthenolide on prostate tumor-initiating cells: An integrated molecular profiling approach

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

Mitochondrial membrane permeabilization in cell death

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

Modes of p53 regulation

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

Evidence that IL-6-type cytokine signaling in cardiomyocytes is inhibited by oxidative stress: parthenolide targets JAK1 activation by generating ROS

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

Abrogation of constitutive STAT3 activity sensitizes human hepatoma cells to TRAIL-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

Parthenolide, a sesquiterpene lactone from the medical herb feverfew, shows anticancer activity against human melanoma cells in vitro.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

Knockdown of STAT3 expression by RNA interference inhibits the induction of breast tumors in immunocompetent mice

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

p53 upregulates death receptor 4 expression through an intronic p53 binding site

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

Dual role of the anti-inflammatory sesquiterpene lactone: regulation of life and death by parthenolide

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

Microtubule-interfering activity of parthenolide

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

Molecular basis of parthenolide-dependent proapoptotic activity in cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

The synthetic cannabinoid WIN 55,212-2 sensitizes hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating p8/CCAAT/enhancer binding protein homologous protein (CHOP)/death rec

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer model

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

Human hepatocellular carcinoma cells resist to TRAIL-induced apoptosis, and the resistance is abolished by cisplatin.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

Antimyeloma effects of a sesquiterpene lactone parthenolide.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

Oxidative stress-mediated apoptosis. The anticancer effect of the sesquiterpene lactone parthenolide

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

Identification and characterization of a new member of the TNF family that induces apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

The JAK kinases: not just another kinase drug discovery target

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

Evaluation of combination chemotherapy: integration of nonlinear regression, curve shift, isobologram, and combination index analyses

1 reference

https://api.crossref.org/works/10.1002%2FJCP.22494

21 January 2018

Identifiers

10.1002/JCP.22494

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21413021%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21413021%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54603551&oldid=1855148957"